Compare Stocks: IONS vs. PRAX vs. AXSM vs. ABVX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IONSPRAXAXSMABVX
Market Snapshot
Current market context for the selected companies.
IONS
$63.14
Market Cap
$10.53B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
PRAX
$372.00
Market Cap
$10.54B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
AXSM
$204.96
Market Cap
$10.85B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
ABVX
$116.39
Market Cap
10.17B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
Performance
Absolute returns and relative performance versus SPY.
| Metric | IONS | PRAX | AXSM | ABVX |
|---|---|---|---|---|
| 1 Month | +16.8% | +27.8% | -9.9% | -2.1% |
| 1 Month vs SPY | +11.2% | +22.2% | -15.5% | -7.7% |
| 3 Months | -18.3% | +5.5% | -12.0% | -10.1% |
| 3 Months vs SPY | -20.5% | +3.4% | -14.1% | -12.2% |
| 6 Months | -21.7% | +9.3% | +25.6% | -2.6% |
| 6 Months vs SPY | -33.5% | -2.5% | +13.8% | -14.4% |
| 1 Year | +49.7% | +676.6% | +69.2% | +46.0% |
| 1 Year vs SPY | +30.3% | +657.2% | +49.7% | +26.6% |
| 2 Years | +32.8% | +647.6% | +135.3% | +898.2% |
| 2 Years vs SPY | -5.7% | +609.0% | +96.7% | +859.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.